• 03 NOV 2017
    • 0

    November Is Pancreatic Cancer Awareness Month

    In honor of National Pancreatic Cancer Awareness Month (November) and World Pancreatic Cancer Day (Nov. 16th), we’ve compiled some important statistics about the disease—and how we plan to combat it. Pancreatic cancer is one of the deadliest forms of cancer. According to the American Cancer Society, more than 53,000 new cases of pancreatic cancer will

    Read more →
    • 04 APR 2017
    • 0

    Celluar Microencapsulation – Cell Encapsulation for Drug Delivery & Disease Treatment

    INTRODUCTION Regenerative medicine is not all that new; tissue and organ transplants have been around for decades. However, the Mayo Clinic has said, “But advances in developmental and cell biology, immunology, and other fields have unlocked new opportunities to refine existing regenerative therapies and develop novel ones.” It has also stated, “Regenerative medicine is a

    Read more →
    • 13 JUN 2016
    • 0

    Promising Diabetes Treatment Using Human Liver Cells May Be on the Horizon

    Diabetes News Journal Article By Katie McCallum A collaboration between Prof. Ann Simpson of the University of Technology Sydney (UTS) in Australia and a U.S. clinical stage biotechnology company, PharmaCyte Biotech, shows promise for a unique alternative therapy for a generation of type 1 diabetes patients. Utilizing human liver cells engineered to supply the

    Read more →
    • 05 OCT 2015
    • 0

    Imaging to Cure Cancer: Valuable Contribution of Radiology for Clinical Trial Success

    Written by Ι Dr. Ron Korn, Founder, Chairman and Chief Medical Officer at Imaging Endpoints “I keep dreaming of a future, a future with a long and healthy life, not lived in the shadow of cancer but in the light” – Patrick Swayze Introduction Pancreatic cancer is one of the most lethal malignancies. It is often

    Read more →
    • 02 SEP 2015
    • 0

    Oncology KOLS: An Important Piece of the Puzzle

    PharmaVOICE Magazine September 2015 Edition NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable. The oncology market is changing. Scientific advances are transforming cancer treatments, with outcomes for patients improving. At the same time, patients are challenged by access concerns

    Read more →
    • 05 AUG 2015
    • 0

    PharmaCyte Seeks to Solve Pancreas Puzzle with Cell-in-a-Box®

    BioWorld Article by Marie Powers News Editor Considering its relatively inconspicuous presence in the body, the pancreas can wreak havoc on human health through two major diseases: diabetes and pancreatic cancer. Both can be deadly – the former from the condition itself or from long-term complications and the latter from advanced disease that may be

    Read more →
    • 04 AUG 2015
    • 0

    The Benefits Of Establishing A Consortium For Drug R&D

    By Kenneth L. Waggoner, Chief Executive Officer, President, General Counsel and Chairman of the Board, PharmaCyte Biotech Scientific research is a cooperative enterprise. Researchers working today are standing on the shoulders of those who have gone before, and they are paving the way from the next generation of scientists. Today’s researchers attend conferences and exchange

    Read more →
    • 23 JUN 2015
    • 0

    PharmaCyte Biotech and UTS to Partner on Diabetes Treatment

    PharmaCyte Biotech will partner with the University of Technology Sydney (UTS) to co-develop the company’s preclinical treatment for insulin-dependent diabetes that uses its Cell-in-a-Box® technology. The value of the collaboration was not disclosed. The diabetes treatment consists of Melligen cells—human non-pancreatic insulin-producing cells—developed

    Read more →
    • 17 JUN 2015
    • 0

    Novel Pancreatic Cancer Drug May also Combat Malignant Ascites

    Treatment Being Studied Involves a Combo of Low-Dose Cancer Prodrug Ifosfamide and Cell-in-a-Box Capsules

      SILVER SPRING, Md.—Ascites, which is the buildup of fluid in the abdominal cavity, is called malignant ascites when caused by cancer and accounts for 10 percent of people with ascites. Malignant ascites appears most often in people with breast,

    Read more →
    • 04 JUN 2015
    • 0

    Additional Research Using Novel Cell Encapsulation Technology Pushes Forward in the Treatment of Malignant Ascites

    Newswise — Malignant ascites fluid accumulation is problematic for patients with pancreatic and other abdominal cancers. As this fluid accumulates, the abdomen becomes swollen and painful. In addition, because it contains cancer cells, new tumors can form at locations in a patient away from the source of the original cancer. If left untreated, malignant ascites

    Read more →